Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Microbix J (MBX.TO)

Microbix J (MBX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 33,946
  • Shares Outstanding, K 138,553
  • Annual Sales, $ 18,585 K
  • Annual Income, $ -2,246 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.47
  • Price/Sales 2.05
  • Price/Cash Flow N/A
  • Price/Book 1.28
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.03
  • Most Recent Earnings $-0.01 on 02/12/26
  • Next Earnings Date 05/21/26
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend 0.275 on 09/02/99
  • Sector Medical
  • INDUSTRY GROUPING:

    SIC-2834 Pharmaceutical Preparations

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $0.00
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2250 +8.89%
on 04/07/26
0.2550 -3.92%
on 03/24/26
+0.0050 (+2.08%)
since 03/13/26
3-Month
0.2100 +16.67%
on 01/21/26
0.2600 -5.77%
on 03/11/26
+0.0050 (+2.08%)
since 01/15/26
52-Week
0.2100 +16.67%
on 01/21/26
0.4100 -40.24%
on 05/05/25
-0.1050 (-30.00%)
since 04/15/25

Most Recent Stories

More News
Stocks in play: Microbix Biosystems Inc.

Will be exhibiting at ESCMID Global 2026 and presenting results of a novel quality assessment product ...

MBX.TO : 0.2450 (unch)
Microbix Exhibiting & Presenting at ESCMID Global 2026

Presenting Results of Novel Product for Quality Control of RNA-based Assays

MBX.TO : 0.2450 (unch)
MBXBF : 0.1683 (+3.19%)
Microbix Announces Annual Meeting Voting Results

MISSISSAUGA, ON / ACCESS Newswire / March 26, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQB:MBXBF) ("Microbix®" or the Company"), a life sciences innovator, manufacturer, and exporter, announces the...

MBX.TO : 0.2450 (unch)
MBXBF : 0.1683 (+3.19%)
Microbix Presents Reference-Material Innovations at EUROGIN

QUANTDx Samples with "Normalized" Viral Loads for Validating HPV Assays

MBX.TO : 0.2450 (unch)
MBXBF : 0.1683 (+3.19%)
Stocks in play: Microbix Biosystems Inc.

Announces that the contract development and manufacturing organization engaged by its funding and commercialization ...

MBX.TO : 0.2450 (unch)
Microbix's Clot-Buster Drug Project Advances

Drug Substance Manufacturing Methods Modernized

MBX.TO : 0.2450 (unch)
MBXBF : 0.1683 (+3.19%)
Microbix Announces Issuance of Stock Options

Using Shareholder-Approved Plan to Incentivize and Retain

MBX.TO : 0.2450 (unch)
MBXBF : 0.1683 (+3.19%)
Microbix Reports Results for Q1 2026

Q1 Revenues of $4.2 million and Controlled Net Loss

MBX.TO : 0.2450 (unch)
MBXBF : 0.1683 (+3.19%)
Stocks in play: Microbix Biosystems Inc.

Welcomes the College of America Pathologists as a customer for Microbix quality assessment products ...

MBX.TO : 0.2450 (unch)
Microbix Welcomes The College of American Pathologists as a Client For Supply of QAPs for PT/EQA Programs

MISSISSAUGA, ON / ACCESS Newswire / February 10, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF) (Microbix®), a life sciences innovator, manufacturer, and exporter, is pleased to welcome the College...

MBX.TO : 0.2450 (unch)
MBXBF : 0.1683 (+3.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test...

See More

Key Turning Points

3rd Resistance Point 0.2517
2nd Resistance Point 0.2483
1st Resistance Point 0.2467
Last Price 0.2450
1st Support Level 0.2417
2nd Support Level 0.2383
3rd Support Level 0.2367

See More

52-Week High 0.4100
Fibonacci 61.8% 0.3336
Fibonacci 50% 0.3100
Fibonacci 38.2% 0.2864
Last Price 0.2450
52-Week Low 0.2100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.